Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BCYC
#3484
Bicycle Therapeutics plc American Depositary Shares
5.0
6
USD
+1.61%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+1.61%
Mudança mensal
+4.98%
Mudança em 6 meses
-35.95%
Mudança anual
-30.49%
Fechamento anterior
4.9
8
Abrir
5.0
6
Bid
Ask
Mínimo
5.0
6
High
5.0
6
Volume
42
Mercados
Ações
Cuidados de saúde
BCYC
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
23.09 M
29.6 M
30.02 M
37.88 M
47.71 M
50.27 M
—
Valuation ratios
Enterprise value
429.4 M
1.4 B
605.8 M
217.05 M
-171.56 M
-272.2 M
-1.3 B
Price to earnings ratio
—
-22.8
-7.89
-3.63
-4.83
-2.24
-9.02
Price to sales ratio
—
130.42
61.52
24.33
23.1
6.76
69.17
Price to cash flow ratio
—
-103.12
-10.33
-10.83
-4.95
-1.96
-9.46
Price to book ratio
—
4.41
3.29
1.77
1.03
0.8
1.3
Enterprise value to EBITDA ratio
-8.18
-21.23
-4.97
-0.98
1
1.11
2.5
Profitability ratios
Return on assets %
-0.32
-0.14
-0.27
-0.3
-0.18
-0.31
-0.27
Return on equity %
-0.53
-0.19
-0.42
-0.49
-0.21
-0.36
-0.33
Return on invested capital %
-163.78
-271.48
-901.36
-1 275.56
-1 685.04
-2 598.15
-2 105.36
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-500.1
-560.98
-806.56
-704.13
-594.96
-340.38
-4 279.65
EBITDA margin %
-487.81
-548.94
-781.06
-679.86
-574.62
-331.53
-4 187.43
Net margin %
-490.95
-571.25
-779.35
-669.72
-479.18
-301.66
-3 858.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.73
12.65
6.92
8.08
13.81
11.98
47.89
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.04
0.03
0.05
0.05
0.09
0.09
Solvency ratios
Debt to assets ratio
0.09
0.09
0.11
0.08
0.04
—
—
Debt to equity ratio
0.16
0.12
0.16
0.12
0.05
—
—
Long term debt to total assets ratio
0.09
0.06
0.07
0.05
0.03
—
—
Long term debt to total equity ratio
0.15
0.09
0.11
0.08
0.04
—
—
Per share metrics
Operating cash flow per share
—
-0.59
-2.9
-1.7
-2.83
-3.6
-3.61
EBIT per share
—
-2.62
-3.93
-5.34
-3.61
-3.57
-3.57
EBITDA per share
—
-2.56
-3.81
-5.15
-3.48
-3.47
-3.47
Total debt per share
—
1.67
1.49
1.26
0.69
—
—
Cash per share
—
17.5
11.43
14.79
15.11
9.07
40.3
Net current asset value per share
—
18.3
12.45
15.79
15.95
9.86
44.5
Tangible book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
Working capital per share
—
16.85
10.66
13.83
14.8
9.03
40.73
Book value per share
—
13.82
9.13
10.42
13.62
8.8
38.09
Notícias
RBC Capital reduz preço-alvo da Bicycle Therapeutics para US$ 7
Needham reduz preço-alvo da Bicycle Therapeutics após atraso em estudo
Citizens reduz preço-alvo da Bicycle Therapeutics após mudança estratégica
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Truist reduz preço-alvo da Bicycle Therapeutics após mudança no pipeline
Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift
Lucro da Bicycle Therapeutics superou projeções por $0,65; receita supera estimativas
Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates
Seres names Richard Kender as executive chair and interim CEO
Bicycle Therapeutics anuncia mudanças na liderança para próxima fase
Bicycle Therapeutics announces leadership changes for next phase
Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock